KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Medpace Holdings (MEDP) over the last 6 years, with Q4 2025 value amounting to $29.5 million.

  • Medpace Holdings' Shares Outstanding (Diluted Average) fell 776.85% to $29.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $29.5 million, marking a year-over-year decrease of 776.85%. This contributed to the annual value of $29.5 million for FY2025, which is 776.85% down from last year.
  • According to the latest figures from Q4 2025, Medpace Holdings' Shares Outstanding (Diluted Average) is $29.5 million, which was down 776.85% from $29.7 million recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' Shares Outstanding (Diluted Average) peaked at $37.7 million during Q4 2021, and registered a low of $29.5 million during Q4 2025.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $32.0 million (2024), whereas its average is $32.8 million.
  • Per our database at Business Quant, Medpace Holdings' Shares Outstanding (Diluted Average) plummeted by 1157.46% in 2023 and then soared by 78.21% in 2024.
  • Medpace Holdings' Shares Outstanding (Diluted Average) (Quarter) stood at $37.7 million in 2021, then dropped by 10.68% to $33.7 million in 2022, then decreased by 5.43% to $31.8 million in 2023, then increased by 0.54% to $32.0 million in 2024, then fell by 7.77% to $29.5 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $29.5 million in Q4 2025, compared to $29.7 million in Q3 2025 and $30.2 million in Q2 2025.